Population Health Research Institute
About PHRI

Our People
The people that make PHRI what it is

 < back


Scientific Leadership  

 

 

 

 

Dr. Salim Yusuf
Executive Director

Dr. Yusuf is a Professor of Medicine at McMaster University, Executive Director of the Population Health Research Institute, and is Vice-President of Research at Hamilton Health Sciences. He holds a Heart and Stroke Foundation of Ontario Research Chair, was a Senior Scientist of the Canadian Institutes of Health Research (1999-2004), and has received (among others) the Lifetime Research Achievement award of the Canadian Cardiovascular Society, the Paul Wood Silver Medal of the British Cardiac Society, the European Society of Cardiology gold medal, the American Heart Association Clinical Research Award, and over 35 other international and national awards for research, induction into the Royal Society of Canada, appointment as an Officer of the Order of Canada, and induction into the Canadian Medical Hall of Fame. He has led over 50 major trials or epidemiologic studies, and several of them have changed medical practice. He has published over 800 articles in refereed journals, rising to the second most cited researcher in the world for 2011. He is President-elect of the World Heart Federation, where he is initiating an Emerging Leaders program in 100 countries with the aim of halving the CVD burden globally within a generation.

 

 

 

Dr. Hertzel Gerstein
Deputy Director

Dr. Gerstein is an Endocrinologist and Professor at McMaster University and Hamilton Health Sciences, where he holds the Population Health Institute Chair in Diabetes Research. He is also Director of the Division of Endocrinology & Metabolism and Director of the Diabetes Care and Research Program. Dr. Gerstein has pioneered the application of large simple outcome trials to people with diabetes globally, and developed the concept of dysglycemia as an important risk factor for many of the serious health outcomes that afflict people with an elevated glucose level regardless of diabetes status. He currently leads clinical trials and epidemiologic studies related to: a) the prevention and therapy of diabetes and its many consequences, and b) the role of dysglycemia and relative insulin insufficiency on the development of diabetes, cardiovascular disease, cognitive impairment and other chronic conditions. His research spans over 50 countries, and has been funded by the Canadian Institutes of Health Research, the National Institutes of Health, the Heart and Stroke Foundation, the Canadian Diabetes Association and Industry. Key studies in which he has played or continues to play a major leadership role include HOPE, MICRO HOPE, ACCORD, DREAM, EpiDREAM, ORIGIN, TIDE, ACE, ELIXA and REWIND. Dr. Gerstein has published more than 300 papers, editorials and commentaries, mainly on diabetes-related issues and co-edited the textbook Evidence-Based Diabetes Care. He is an Associate Editor for ACP Journal Club, and is on the editorial board of the Journal of Diabetes and Lancet Diabetes and Endocrinology. He has received several honors including the Canadian Diabetes Association’s Young Scientist Award (1999), Frederick G. Banting award (1999), Charles H. Best award (2007) and Lifetime Achievement Award (2012).

 

 

Dr. Koon Teo
Associate Director

Dr. Teo is an Associate Director at the Population Health Research Institute providing senior leadership to the institute's direction and research studies. Dr. Teo is a Professor of Medicine in the Department of Cardiology at McMaster University and an Associate Member of the Department of Clinical Epidemiology & Biostatistics. Previously, Dr. Teo served as the acting director of the Division of Cardiology at McMaster University and Hamilton Health Sciences. His wide range of work includes 16 book chapters and 256 articles featured in over 15 international medical journals. He was also the Canadian Principal Investigator for the COURAGE trials the results of which impacts the practice of cardiology worldwide and of the Canadian Institute for Health Research funded FAMILY study examining the origin of obesity and cardiometabolic risk factors in early childhood. He is also co-PI in the large international epidemiology study (PURE) and the International Polycap Trials (TIPS).

 

Dr. Sonia Anand
Associate Director

Dr. Anand is a Professor of Medicine and Epidemiology at McMaster University, and the Director of the Population Genomics Program at McMaster and at the PHRI, Hamilton Health Sciences. She currently holds a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. Her present research focuses upon the environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease. She has published over 200 articles in peer review journals and has recently received the Queen Elizabeth II Diamond Jubilee Medal.



Dr. Heather Arthur
Women's Health

Dr. Arthur is a Principal Investigator for the Women's Health Program at the Population Health Research Institute. Dr. Arthur has been the Heart and Stroke Foundation of Ontario's endowed chair in cardiovascular nursing research and an Associate Professor at the School of Nursing in the faculty of Health Sciences. Now Dr. Arthur is the Co-director of the Cardiac and Vascular Nursing Science Unit at the Hamilton Health Sciences Corporation. Dr. Arthur studied her Bachelor of Science degree in nursing at McMaster University in Hamilton, Ontario. Dr. Arthur later received both her Master of Science in Cardiac Nursing and her Doctor of Philosophy in Medical Science from the University of Toronto. Dr. Arthur is the recipient of the Cardiovascular Nursing Research Excellence Award from the Canadian Council of Cardiovascular Nurses and the Career Scientist from the Ontario Ministry of Health. She has co-authored a book, written 8 book chapters and published over 70 peer reviewed journal articles.

  

 

Dr. Stuart Connolly 
Arrhythmias

Dr. Connolly is the leading Principal Investigator for the Arrhythmia research program at the Population Health Research Institute. Currently, this program leads many large randomized controlled trials of treatment for the management of atrial fibrillation, bradycardia and defibrillator therapy. These trials include more than 40,000 enrolled patients and involve more than 1,000 centers in 40 countries. Dr. Connolly is also a professor of medicine at McMaster University and the Director of the division of Cardiology at McMaster University and Hamilton Health Sciences. Dr. Connolly holds both his Bachelors of Arts and Medical degree from McGill University. Dr. Connolly has led more than two dozen large randomized controlled trials over the past 20 years and has published over 190 articles.

 

 

Dr. Catherine Demers
Heart Failure/LV Dysfunction

Dr. Demers works on Heart Failure and LV Dysfunction Program at the Population Health Research Institute. She is also an Associate Professor in the Department of Medicine and Division of Cardiology at McMaster University in Hamilton, Ontario. Current research focuses on improving clinical outcomes in older heart failure patients. Dr. Demers held a Career Scientist Award from the Ministry of Health and Long Term Care of Ontario (2003-2010). She has published over 40 Articles in peer review journals.

 

 

Dr. P.J. Devereaux
Perioperative Ischema

Dr. Devereaux holds a Heart and Stroke Foundation of Ontario Career Investigator Award. He is the Head of Cardiology and the Perioperative Cardiovascular Clinical Program at the Juravinski Hospital and Cancer Centre. He is also the Scientific Leader of the Anesthesiology, Perioperative Medicine, and Surgical Research Group at the Population Health Research Institute. The focus of his clinic research is vascular complications around the time of surgery. He is undertaking several large international RCTs and observational studies addressing this issue. Dr. Devereaux has published over 160 peer reviewed papers and 40 editorials, book chapters, and commentaries.

 

 

Dr. Jeff Healey
Arrhythmias

Dr. Healey is the director of arrhythmia services and associate professor of medicine at McMaster University in Hamilton, Ontario Canada. He is also a clinical trialist, and member of the Population Health Research Institute. His research involves the conduct of randomized clinical trials and large registries in the fields of cardiac arrhythmias and cardiac devices. His area of research focus is studying the effect of risk factors, and risk factor modification on the development of atrial fibrillation and its complications, such as stroke. Dr. Healey has published over 175 articles in peer reviewed journals. Dr. Healey has received numerous grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation and from industry. He is the co-chair of the Canadian Cardiovascular Society’s Atrial Fibrillation Guidelines Committee, co-chair of the CCS Guidelines for Perioperative management of pacemakers and defibrillators and past chair of the Cardiac Care Network of Ontario’s Heart Rhythm Working group. Dr. Healey is the principal investigator and chair of the Canadian Stroke Prevention Intervention Network (CSPIN), a ten-year network grant funded by the Canadian Institutes of Health Research, The Heart and Stroke Foundation of Canada and Industry. .

 

 

Dr. Andre Lamy
CV Surgery

Dr. Lamy is a cardiac surgeon practicing at the Hamilton Health Sciences since 1996 and Professor in the Department of Surgery at McMaster University and an Associate member in the in the Department of Clinical Epidemiology and Biostatistics at McMaster University. Dr. Lamy led the Canadian Institute of Health Research funded CORONARY trial, which evaluates off-pump CABG surgery versus on-pump CABG surgery in 4752 patients. The results were published in the New England Journal of Medicine in 2012 and 2013.

 

Dr. Eva Lonn
Atherosclerosis Imaging and Cardiovascular Prevention

Dr. Lonn is a Principal Investigator for both the Atherosclerosis Imaging and Cardiovascular Prevention programs at the Population Health Research Institute. She is currently a Professor of Medicine in the Division of Cardiology at McMaster University in Hamilton, Ontario. Dr. Lonn's research interests are in clinical trials in cardiovascular prevention, understanding of the determinants of atherothrombotic cardiovascular diseases, including traditional and novel risk factors and ultrasound imaging in atherosclerosis. She has lead or co-lead several large trials in cardiovascular prevention including the HOPE-2 and HOPE-3 studies and several large imaging studies in atherosclerosis, including the SECURE, STARR and GRACE trials. She served for many years on the Canadian Cardiovascular Society Council and Executive Committee and was recently elected as Ontario Governor on the American College of Cardiology Board of Governors. Dr. Lonn has published over 200 peer reviewed articles, and 8 book chapters.

 

Dr. Robert McKelvie
Heart Failure/ LV Dysfunction

Dr. McKelvie is the Chair of the Canadian Cardiovascular Society Heart Failure Guidelines; Chair of the Quality Indicators Working Group for Heart Failure of the Canadian Cardiovascular Society/Public Health Agency of Canada; Chair of the Canadian Cardiovascular Society HFCC National Workshop Initiative; Chair of the Cardiac Care Network, Heart Failure Working Group; and a Primary Panelist, of the Canadian Cardiovascular Society Guidelines in Pediatric Heart Failure. Dr. McKelvie is the Medical Director of the Cardiac Health and Rehabilitation Centre as well as the Medical Director of the Heart Failure Program, at the Hamilton Health Sciences. He is a Professor of Medicine at McMaster University, in Hamilton, Ontario. Dr. McKelvie has written over 185 peer reviewed articles.

 

 

Dr. Shamir Mehta
Coronary Interventional Health Delivery and Acute Coronary Syndrome

Dr. Mehta is a Principal Investigator for both the Acute Coronary Syndrome and the Interventional Cardiology programs at the Population Health Research Institute. He is Professor of Medicine at McMaster University and Director of the Interventional Cardiology program at Hamilton Health Sciences. Dr. Mehta received a Canadian Institutes of Health Research New Investigator Career Award. His research focuses on the role and timing of invasive therapies in patients with acute ischemic heart disease and the evaluation of novel antiplatelet and anticoagulant therapies in these patients. He has led several large pragmatic randomized trials evaluating invasive interventional strategies in patients with acute coronary syndromes. He has also lead multinational randomized trials evaluating novel antiplatelet and anticoagulant therapies to improve outcomes in patients experiencing a heart attack. Dr. Mehta has published 125 original research papers in several medical journals including The New England Journal of Medicine, The Lancet, JAMA, and Circulation. Dr. Mehta's success in research has earned him a coveted Canada's Top 40 under 40TM award in 2004.

 

 

Dr. Carlos Morillo
Arrhythmias and Developing Countries

Dr. Morillo is a Principal Investigator for both the Arrhythmias and Developing Countries research programs at the Population Health Research Institute. Presently, he is a Professor of Medicine, Director of the Syncope and Autonomic Dysfunction Unit, and the Program Director of the Cardiac Electrophysiology and Autonomic Physiology Fellowship. He has held a Heart & Stroke Foundation of Canada Research Fellowship. His main research interests are related with the development of clinical trials in the area of cardiac arrhythmias, syncope and treatment of Chagas Disease. Dr. Morillo has a long-lasting interest in developing new therapeutic approaches for the treatment of atrial fibrillation, autonomic disorders, and Chagas disease. Dr. Morillo has published more than 230 articles in peered reviewed journals; over 320 abstracts and 35 book chapters in well know Cardiology textbooks. He is also the recipient of many prestigious awards including the Charles Pfizer Research Award, the National Academy of Medicine- Aventis Clinical Research Award as well as the Award for Best Researcher from the Sociedad Colombianade Cardiolgia and was selected as one of the 10 most influential Hispanic-Canadians in 2010.

 

 

Dr. Katherine Morrison
Childhood Risk Factors

Dr. Morrison is the leading Principal Investigator for the Childhood Risk Factors Research program at the Population Health Research Institute. She is currently an Associate Professor in the Department of Pediatrics at McMaster University in Hamilton, Ontario. She has received various awards including the Excellence in Pediatric Research Award as well as a Heart and Stroke Foundation Fellowship in Preventive Cardiology. Dr. Morrison is supported in her research by the Canadian Institutes of Health Research, the Heart and Stroke Foundation, HAHSO and the McMaster Children’s Hospital Foundation.

 

Dr. Madhu Natarajan
Coronary Interventional Health Delivery

Dr. Natarajan is an Interventional Cardiologist and Principal Investigator for the Coronary Interventional Health Delivery and Knowledge Translational and Implementation programs at the Population Health Research Institute. He is a Professor at McMaster University, Director of Catheterization laboratories at Hamilton Health Sciences and Site Director for Cardiology at Hamilton General Hospital. Dr. Natarajan has published over 85 articles during his medical research career. His other activities include appointed member for the Cardiac Care Network of Ontario where he is currently chair of STEMI-EMS Committee, appointed member of the Royal College Cardiology National Examination Board and program lead for Regional STEMI network in LHIN-4 Ontario.

 

 

Dr. Martin O'Donnell
Stroke & Cognitive Function

Dr. O'Donnell is the primary Principal Investigator for the Strokes/Cognitive Function research program at the Population Health Research Institute. Dr. O'Donnell is the William Walsh Endowed Chair in Internal Medicine and is also an Associate Professor in the Department of Medicine in the Internal, Geriatric and Thrombosis Division at McMaster University in Hamilton, Ontario. He holds an MB BCh from University College in Cork, an MRCPI from the Royal College of Physicians in Ireland. Dr. O'Donnell also holds a PhD in Health Research Methodology from McMaster University. Dr. O'Donnell is the winner of several prestigious awards like the Canadian Institute for Health Research's New Investigator Award.

 

Dr. Tej Sheth
Atherosclerosis Imaging

Dr. Tej Sheth is a Principal Investigator for the Atherosclerosis Imaging program at the Population Health Research Institute. He is currently an Associate Professor in the Department of Medicine at McMaster University. Dr. Sheth has received many awards such as the Research Career Development Award from McMaster University and the Solmon Award from the Division of Cardiology at Sunnybrook Hospital.

 

 

Dr. Richard Whitlock
CV Surgery

Dr. Whitlock is a Principal Investigator for the Cardiovascular Surgery program at the Population Health Research Institute. Dr. Whitlock is currently an Assistant Professor within the Department of Surgery at McMaster University. Dr. Whitlock has been awarded many honors for his various accomplishments including the Ted Thomas Prize from McMaster University and the Anemia Institute's Award for Research and Education. He is a lead investigator for the CIHR funded studies SIRS, LAAOS III, and TRICS III. He has published 41 articles in peer reviewed journals.

 

 

Dr. Zubin Punthakee
Cardiovascular Prevention Program and the Childhood Risk Factors Program

Dr. Punthakee is a Principal Investigator for the Cardiovascular Prevention program and the Childhood Risk Factors program at the Population Health Research Institute. He is an Associate Professor in the Departments of Medicine and Pediatrics, Division of Endocrinology & Metabolism at McMaster University. He has been supported by Research Career Awards from Hamilton Health Sciences and the Department of Medicine at McMaster University, and holds research grants from agencies including the Canadian Institutes of Health Research. He has had leadership roles in the TIDE trial, ORIGINALE study and RICH LEGACY study. He has published 22 articles.

 

 

Dr. Andrew Mente
Clinical Epidemiology and Biostatistics

Dr. Mente is a Principal Investigator for the Epidemiology program at the Population Health Research Institute. He received his doctoral degree in Epidemiology from the University of Toronto. He completed post-doctoral training in cardiovascular epidemiology at McMaster University, and is currently an Assistant Professor in Clinical Epidemiology and Biostatistics at McMaster University. Dr. Mente has received a Research Fellowship from the Heart and Stroke Foundation of Canada, and a Research Early Career Award from Hamilton Health Sciences. Dr. Mente is currently working in the Population Urban and Rural Epidemiological (PURE) study, and is interested in the role of essential minerals (sodium, potassium, calcium, magnesium) and dietary fatty acids in cardiovascular diseases in populations around the world. He has published 41 papers and 2 Chapters.

 

 

Dr. Robby Nieuwlaat
Knowledge Translation

Dr. Nieuwlaat is a Principal Investigator for the Knowledge Translation program at the Population Health Research Institute, and Assistant Professor within the Department of Clinical Epidemiology & Biostatistics at McMaster University. Dr. Nieuwlaat holds a Masters of Health Sciences and Epidemiology, and a PhD in Clinical Epidemiology from Maastricht University in The Netherlands. Dr. Nieuwlaat received a Rubicon award from the Netherlands Organization for Scientific Research (NWO) for his post-doctoral research at the Population Health Research Institute, and has published over 50 peer-reviewed scientific papers. His main research interests include the assessment of evidence-practice gaps and barriers to recommended care, as well as interventions to improve the implementation of recommended care and thereby population cardiovascular outcomes.

 

 

Dr. Robert Hart
Stroke Program

Dr. Hart is the leading Principal Investigator for the Stroke program at the Population Health Research Institute. He is a Vascular Neurologist, Professor of Medicine (Neurology) and the Michael DeGroote Endowed Chair in Stroke Research at McMaster University and Hamilton Health Sciences, and co-Director of the McMaster/Hamilton Health Sciences Stroke Fellowship. After completing a fellowship in cerebrovascular disease at the Oregon Health Sciences University, he spent most of his career at the University of Texas Health Science Center in San Antonio before relocating to McMaster University in September 2011. He has a long-standing interest in stroke, stroke research, and clinical trials. He has directed several randomized clinical trials serving as the principal investigator of the NIH/NINDS-sponsored Stroke Prevention in Atrial Fibrillation (SPAF) I, II and III trials (1987-2000). Antithrombotic therapies to prevent stroke in atrial fibrillation and especially novel oral anticoagulants are areas of special interest. He has published 250 articles in peer-reviewed journals.

 

 

Dr. Guillaume Pare
Genetic and Molecular Epidemiology Laboratory

Dr. Pare is a Principal Investigator for the Genetic Epidemiology program at the Population Health Research Institute. He is also Assistant Professor of Pathology and Molecular Medicine at McMaster University and Director of the Genetic and Molecular Epidemiology Laboratory at the PHRI/TAARI. Dr. Pare is a Medical Biochemist with board certification from the Royal College of Physicians and Surgeons of Canada. Dr. Pare completed a Master’s in Human Genetics at McGill University under the supervision of renowned geneticist Dr. Thomas Hudson. He further trained in genetic epidemiology with Dr. Paul Ridker at Harvard Medical School. Dr. Pare currently holds a Canada Research Chair in Genetic and Molecular Epidemiology. His clinical interests are centered on lipoprotein disorders, obesity and cardiovascular disease prevention. His corresponding research interests are in cardiovascular genetics, biomarker development and pharmacogenomics. His latest contributions are the characterization of the common genetic determinants of inflammatory markers, lipoprotein fractions and antiplatelet agent’s action, as well as development of novel statistical tools for analysis of genetic datasets. He has published 84 papers.

 

 

Dr. Hisham Dokainish
Echocardiography

Dr. Dokainish is a Principal Investigator for the echocardiography program at the Population Health Research Institute. He is currently Associate Professor of Medicine, Division of Cardiology at McMaster University, Director of Medical Diagnostic Units and Echocardiography, Hamilton Health Sciences. His interests include cardiac hemodynamics, myocardial performance and diastolic dysfunction and diastolic heart failure. He has published 50 scientific articles in peer-reviewed journals.

 

 

Dr. John Eikelboom
Thrombosis

Dr. Eikelboom is Associate Professor in the Department of Medicine, McMaster University, and haematologist in the Thrombosis Service, Hamilton General Hospital, Ontario, Canada. He originally trained in Internal Medicine and Haematology in Perth, Australia and subsequently moved to Hamilton to take up a Tier II Canada Research Chair in Cardiovascular Medicine. Dr Eikelboom has co-authored more than 350 articles in peer-reviewed journals. His current research, supported by the Canadian Institutes for Health Research, the Heart and Stroke Foundation and the National Health and Medical Research Council of Australia, focuses on the efficacy and safety of antithrombotic therapies, outcomes after blood transfusion and bleeding, and the mechanisms of variable response to antiplatelet drugs.

 

 

Dr. Sanjit Jolly
Interventional Cardiology

Dr. Jolly is an interventional cardiologist at Hamilton Health Sciences and associate professor at McMaster University in Hamilton, Canada. He has formal training in clinical trials with a M.Sc. in Health Research Methodology from McMaster University. He was the principal investigator of the RIVAL trial, a randomized trial of 7021 patients comparing radial and femoral access for coronary intervention. He is also the principal investigator trial of the ongoing TOTAL trial, an international randomized trial (N=10,700) of thrombectomy during primary PCI.

 

 

Dr. J-D Schwalm

Dr. Schwalm is a fulltime interventional cardiologist and assistant professor at Hamilton Health Sciences/McMaster University. Dr. Schwalm is completing a Master of Science in Epidemiology at the University of Ottawa. His area of interest is knowledge translation and he is Principal Investigator of two ongoing cluster-randomized controlled trials. He has published 24 papers.

 

 

Dr. Mike Sharma

Dr. Sharma is an investigator in the Stroke program at the Population Health Research Institute and Hamilton Health Sciences. He is a stroke neurologist who completed his fellowship at McGill and the University of Ottawa. Dr Sharma relocated to McMaster in 2013 and has an interest in clinical trials in secondary stroke prevention, covert stroke and economics of stroke care. He is the Chair of the Canadian Stroke Consortium and was the Deputy Director for Clinical affairs and Health Policy of the Canadian stroke Network, one of Canada’s Networks of Centers of Excellence. He has published 31 papers in peer review articles.

 

 

Dr. Harriette Van Spall

Dr. Van Spall is a Principal Investigator for the Knowledge Translation and the Heart Failure programs at the Population Health Research Institute. She is an Assistant Professor in the Division of Cardiology and Department of Medicine at McMaster University. She earned her Doctor of Medicine degree from the University of Toronto, and a Master of Public Health degree from the Harvard School of Public Health. She completed postgraduate training in Internal Medicine, Cardiology, and Echocardiography at the University of Toronto. Dr. Van Spall's research activities are in quality of care and outcomes, knowledge translation, and health systems improvement pertaining to Heart Failure and other chronic cardiovascular diseases. She has won several research awards, and her work has been published in high-impact medical journals, including JAMA, Lancet, Circulation, and Annals of Internal Medicine.

 

 

Dr. Michael Walsh

Dr. Walsh is a Nephrologist and Assistant Professor at McMaster University and St. Joseph’s Healthcare. He holds a Kidney Research Scientist Core Education and National Training Program New Investigator award through the Canadian Institutes of Health Research and the Kidney Foundation of Canada. Dr. Walsh has been awarded several honors including the Chalmers Prize from the Society for Clinical Trials and the Detweiller Traveling Scholar Award from the College of Physicians and Surgeons of Canada. He has published 63 papers and 2 book chapters.

 

 

Dr. Natalia Yakubovich
Diabetes Remission

Dr. Yakubovich is the Joint Principal Investigator for the Diabetes Remission program at the Population Health Research Institute. She received her medical degree from the University of British Columbia. After completing her Internal Medicine and Endocrinology training, she pursued MSc in Health Research Methodology at McMaster University and was recently hired as an Assistant Professor in the Division of Endocrinology. Dr. Yakubovich has received peer-reviewed research funding from CIHR and Canadian Diabetes Association and is supported by the Medicine Internal Career Award from McMaster University. Her research interests include remission of prediabetes and type 2 diabetes, and the relationship between dysglycemia and ectopic fat deposition.

 


Organizational Leadership  (back to top)

 

 

 

Ms. Janette Panhuis 
Chief Operating Officer

Ms. Panhuis joined PHRI in 2009 as the Director, Quality Assurance responsible for Quality Systems, moving into the Chief Operating Officer position in June 2011.   In addition to bringing over 10 years of pharmaceutical industry experience in Quality Assurance, Janette has the underlying clinical training and expertise to support  and direct operations of PHRI research and development. Prior to her QA work, Ms. Panhuis held roles in the health-research environment including Cardiovascular ICU nursing at Toronto General Hospital progressing to senior administrative roles at the hospital before moving into Clinical Trial Project Management and Research Administration in industry.  Ms. Panhuis holds a Masters of Business Administration from York University and a Bachelor of Science in Nursing from the University of Western Ontario.

 

 

Ms. Jackie Bosch 
Project Director

Ms. Bosch is a Project Director at the Population Health Research Institute, Ms. Bosch oversees many studies in the area of primary and secondary cardiovascular disease and diabetes prevention. Ms. Bosch is also an Associate Professor at the School of Rehabilitation Science at McMaster University. Ms. Bosch is part of the organization committee for the Sensible Guidelines working group to improve key aspects or research implementation, is part of the faculty in the international Clinical Trials courses offered by PHRI and is working with Dr. Martin O'Donnell to develop functional outcome measures to compliment the data on cognitive abilities currently collected in many of our studies. In addition, Ms. Bosch is involved in stroke rehabilitation research. Ms. Bosch has published over 40 peer reviewed articles, 6 book chapters and has co-authored a book. Ms. Bosch has been awarded honors such as the Contribution to the School of Rehabilitation Science award at McMaster and the President's Award for outstanding Service.

 

 

Ms. Sumathy Rangarajan
Project Manager 

Ms. Rangarajan is a project manager at the Population Health Research Institute.  Ms. Rangarajan oversees large international studies such as PURE, PURE Offspring, INTERSTROKE and INTERHEART.  Ms. Rangarajan holds both a Bachelor of Science Degree and a Master of Science degree from Pune University in India.

 

 

 

 

Ms. Ellison Themeles
Project Manager

Ms. Themeles is a project manager at the Population Health Research Institute. Ms. Themeles holds both a Bachelor of Arts degree in Gerontology and Sociology and a Master of Science Degree in Health Research Methodology from McMaster University.

 
 

 

 

Ms. Rose Mayhew
Coordinator, Diagnostic Specimen Unit 

Ms. Mayhew is the Coordinator and Department Manager of the Diagnostic Specimen Unit at the Population Health Research Institute. Ms. Mayhew is responsible for the management of specimens from local site collection, processing, and shipping to receipt by the Central Laboratory. Ms. Mayhew studied Chemical Engineering at Mohawk College's School of Applied Arts and Technology, and received her Certified Clinical Research Associate accreditation at McMaster University.

 

 

Dr. Tara McCready
Program Director, CANNeCTIN 

Dr. McCready is the Program Director for the Canadian Network and Centre for Trials Internationally (CANNeCTIN) at the Population Health Research Institute. CANNeCTIN is a national network funded by the CIHR/CFI Clinical Research Initiative program to improve the prevention and treatment of cardiac and vascular diseases and diabetes. Previously the Executive Director of the Canadian Maternal, Infant, Child and Youth Research Network, Dr. McCready holds both a PhD in Biochemistry and a MBA in Technology Commercialization from the University of Alberta.

 

 

 

Dr. Janice Pogue 
Statistics Director

Dr. Pogue is the Statistics Director at the Population Health Research Institute and an Assistant Professor in the department of Clinical Epidemiology and Biostatistics at McMaster University. Dr. Pogue is integral to the maintenance of the numerous databases of many large multicentre randomized clinical controlled trials and epidemiology studies. Dr. Pogue is responsible for the supervision of the statistical activities at the PHRI. Dr. Pogue has published 180 articles, is a co-investigator on numerous grants, and been credited with two Teaching Excellence Awards at McMaster University. Dr. Pogue was also a recipient of the President's Award for Outstanding Service at McMaster University.

 

Ms. Jane Gaviller-Fortune
Director, Quality Assurance

Ms. Gaviller-Fortune is the Director of Quality Assurance at the Population Health Research Institute. Ms. Gaviller-Fortune received her Bachelors of Science in Biochemistry from the University of Waterloo and has over 17 years of experience in clinical quality assurance. Ms. Gaviller-Fortune also holds certification as a Registered Quality Assurance Professional in GCP (RQAP-GCP).

 

 

Mr. Andrew Renner
Director of Information Communications Technology

Mr. Renner is the Director of Information and Communications Technology at the Population Health Research Institute. Mr. Renner provides strategic leadership for the PHRI's telecommunication technology, infrastructure and data management solutions. Mr. Renner received both his Bachelor of Science in Mathematical and Computer Science and his Honours Bachelor of Kinesiology from McMaster University and has over 10 years experience in Information and Communications Technology.

 

 

Ms. Beena Cracknell
Director of Financial and Contract Services

Ms. Cracknell is the Director of Financial and Contract Services. Beena and her team manage over 100 cost centers and 200 members of the PHRI family across the globe in three different currencies and markets. Ms. Cracknell is a Certified General Accountant after studying accounting at Ryerson University.

 
 

Achievements and Awards Granted to PHRI Researchers 

2009

  • Henry N. Neufeld Memorial Lecture and Award, Israel Heart Society: Dr. Salim Yusuf
  • Robert Tigerstedt Award, Finnish Hypertension Society:  Dr. Salim Yusuf


2008

  • Award for Best Researcher, Sociedad Colombiana de Cardiologia: Dr. Carlos Morrillo
  • Distinguished Alumni Award, St. John's Medical College: Dr. Salim Yusuf
  • Gold Medal, European Society of Cardiology: Dr. Salim Yusuf
  • Clinical Research Award, American Heart Association: Dr. Salim Yusuf

 

2007

  • Contribution to the School Award, School of Rehabilitation Science, McMaster University: Ms. Jackie Bosch 
  • Joe Doupe Young Investigator Award, Canadian Society for Clinical Investigation: Dr. P. J. Devereaux
  • Career Achievement Award, 5th Quebec International Symposium on Cardiopulmonary Prevention/ Rehabilitation Centre: Dr. Salim Yusuf
  • Achievement Award, Indo-Canadian Networking Council of Hamilton and Surroundings: Dr. Salim Yusuf

 

2006 

  • Cardiovascular Nursing Research Excellence Award, Canadian Council of Cardiovascular Nurses: Dr. Heather Arthur
  • Ethel Meade Award, Ontario Health Coalition: Dr. P. J. Devereaux 
  • Teaching Excellence Award, McMaster University: Ms.Janice Pogue
  • Scientific Director, Canadian Obesity Network: Dr. Arya Sharma
  • International Lecture of the American College of Cardiology: Dr. Salim Yusuf
  • Jack Hirsh Award for Outstanding Academic Achievement, McMaster University Department of Medicine: Dr. Salim Yusuf
  • Canadian Association of Physicians of Indian Heritage Award: Dr. Salim Yusuf

 

2005

  • Induction into McMaster University Alumni Gallery of Distinction: Dr. Sonia Anand
  • Rick Gallop Award for Research Excellence, Heart & Stroke Foundation of Ontario: Dr. Arya Sharma
  • Michael Smith Prize in Research Finalist, CIHR: Dr. Salim Yusuf
  • Elected Fellow of the Royal Society of Canada: Dr. Salim Yusuf

 

2004

  • American Association for Clinical Chemistry Award for Outstanding Contributions to Clinical Chemistry: Dr. Matthew McQueen
  • Premier's Research Excellence Award (PREA), Ontario Provincial Government: Dr. Parminder Raina

 

2003

  • DRC Gold Medal Oration Award, Chennai, India: Dr. Hertzel Gerstein
  • Somogyi-Sendroy Award by the Upstate New York Section of the American Association for Clinical Chemistry (AACC): Dr. Matthew McQueen
  • Canada's Top 40 Under 40: Dr. Shamir Mehta
  • Paul Wood Silver Medal; British Cardiac Society: Dr. Salim Yusuf
  • Heart and Stroke Foundation Of Canada Lecture: Dr. Salim Yusuf
  • R.T. Hall Professorship, Australian New Zealand Society of Cardiology: Dr. Salim Yusuf
  • Population Sciences Lecturer, European Society of Cardiology, Vienna: Dr. Salim Yusuf

 

2002

  • Induction into McMaster University Alumni Gallery of Distinction: Dr. Hertzel Gerstein
  • Teaching Excellence Award, McMaster University: Ms. Janice Pogue
  • Louis and Artur Lucian Award for Research in Circulatory Disease: Dr. Salim Yusuf
  • Ignacio Chavez Inaugural Lecture; World Congress of Cardiology, Sydney: Dr. Salim Yusuf

 

2001

  • Career Scientist Award, Ministry of Health and Long Term Care of Ontario: Dr. Catherine Demers
  • Canadian Society Internal Medicine Young Investigator Award: Dr. Sonia Anand
  • Prix Galien Canada Research Award: Dr. Salim Yusuf

 

2000

  • Gustav Nylin Medal, Swedish Society of Cardiology: Dr. Salim Yusuf

 

1999

  • Cardiovascular Society Young Investigator Award: Dr. Sonia Anand
  • Canadian Diabetes Association Young Scientist Award: Dr. Hertzel Gerstein
  • Canadian Diabetes Association Frederick G. Banting Award: Dr. Hertzel Gerstein
  • National Health Scholar, NHRDP, Health Canada/CIHR: Parminder Raina
  • Career Research Award of the Canadian Cardiovascular Society: Dr. Salim Yusuf
  • Sol Sherry Award, International Society of Thrombosis & Haemostasis: Dr. Salim Yusuf

 

1998

  • Outstanding Service Profession, Canadian Academy of Clinical Biochemistry: Dr. Matthew McQueen

 

1997

  • Paul P. David Award, Association des Cardiologues du Québec and Merck Frosst Canada Inc: Dr. Catherine Demers
  • Heart and Stroke Foundation Endowed Chair in Cardiovascular Research: Dr. Salim Yusuf

 

1996

  • Canadian Society of Clinical Investigators Award: Dr. Sonia Anand

 

1995

  • Career Scientist Award, R. Samuel McLaughlin Centre for Gerontology, McMaster University: Dr. Parminder Raina

 

 

 

 

 

(back to top)

 

 

?
Print    Email
Population Health Research Institute • Hamilton, Ontario • information@phri.ca